Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psychophysiology and Sertraline in Premenstrual Dysphoric Disorder
NCT02777372Phase 4Completed
- Sponsor
- Johns Hopkins University
- Start
- Apr 2016
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sertraline in Premenstrual Dysphoric Disorder (PMDD), sponsored by Johns Hopkins University. Started Apr 2016; status: completed.
02
Drugs
sertraline
03
Conditions
Premenstrual Dysphoric Disorder (PMDD)
Beyond the preview
Go deeper on NCT02777372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02777372.